| 书目名称 | Intellectual Property Rights in Pharmaceutical Test Data | | 副标题 | Origins, Globalisati | | 编辑 | Adam Buick | | 视频video | | | 概述 | Provides detailed analysis of data exclusivity laws in over 50 international agreements and 25 national jurisdictions.Presents original empirical findings on the impact of data exclusivity on the appr | | 图书封面 |  | | 描述 | .This book considers the intellectual property protection of clinical test data that has been submitted to governments, in particular through test data exclusivity rights. It focuses on how these intellectual property rights first emerged in the early 1980s, how they have globalised over the past four decades, and what impact they have had upon access to medicine. .This book makes a number of significant and original contributions to the literature around the protection of submitted test data. First, the book draws upon the theory of regulatory globalisation to provide an explanation of how intellectual property rights in submitted pharmaceutical test data have become nearly ubiquitous in the legal systems of most major economies. Second, through a comprehensive analysis and synthesis of provisions on the protection of submitted test data in free trade agreements, as well as a comparison of a range of national approaches to the protection of submitted test data, it reveals the broader global regulatory pattern that has given rise to these intellectual property rights. Third, by analysing data on drug approvals in the US, it provides an empirical insight into the impact of test dat | | 出版日期 | Book 2023 | | 关键词 | Test data exclusivity; Access to medicine; Globalisation of intellectual property; data exclusivity; TRI | | 版次 | 1 | | doi | https://doi.org/10.1007/978-3-031-29436-5 | | isbn_softcover | 978-3-031-29438-9 | | isbn_ebook | 978-3-031-29436-5 | | copyright | The Editor(s) (if applicable) and The Author(s), under exclusive license to Springer Nature Switzerl |
The information of publication is updating
|
|
发表于 2025-3-21 19:22:15
